Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Retinal vein occlusion and hyperhomocysteinemia].

J Blondel1, A Glacet-Bernard, N Bayani

  • 1Centre Hospitalier National des Quinze-Vingts, Service II, 28, rue de Charenton, 75012 Paris, France.

Journal Francais D'Ophtalmologie
|May 15, 2003
PubMed
Summary

Elevated homocysteine levels are linked to retinal vein occlusion (RVO), a vascular disease. Further research is needed to confirm if vitamin therapy can prevent or treat RVO.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Branch retinal vein occlusion secondary to hormone replacement therapy in a transgender woman.

Journal francais d'ophtalmologie·2023
Same author

Sutureless intrascleral fixation using a uniquely designed intraocular lens.

Journal francais d'ophtalmologie·2021
Same author

Combined hamartoma of the retina and retinal pigment epithelium with intense pigmentation of the inner retinal layers.

Journal francais d'ophtalmologie·2018
Same author

[Comparison of early management of central retinal vein occlusion with ranibizumab versus hemodilution].

Journal francais d'ophtalmologie·2015
Same author

[Anti-VEGF therapy in the treatment of anterior segment neovascularization secondary to central retinal vein occlusion].

Journal francais d'ophtalmologie·2015
Same author

[Management of macular edema secondary to retinal vein occlusion].

Journal francais d'ophtalmologie·2015

Area of Science:

  • Ophthalmology
  • Cardiovascular Medicine
  • Clinical Research

Background:

  • Elevated plasma homocysteine is a known risk factor for vascular diseases.
  • Retinal vein occlusion (RVO) is a significant cause of vision loss.

Purpose of the Study:

  • To investigate if hyperhomocysteinemia is a risk factor for RVO.
  • To determine if plasma homocysteine levels are a prognostic factor for RVO outcomes.

Main Methods:

  • Plasma homocysteine levels were measured in 101 RVO patients and 29 controls.
  • Correlations between homocysteine, other risk factors, and RVO clinical outcomes were analyzed.

Main Results:

  • RVO patients exhibited significantly higher mean plasma homocysteine levels than controls (11.9 vs 8.6 mmol/l).

Related Experiment Videos

  • Hyperhomocysteinemia was more prevalent in ischemic and bilateral RVO cases, though not statistically significant.
  • No significant relation was found between homocysteine and other vascular risk factors, except hematocrit.

    • Conclusions:

    • Hyperhomocysteinemia appears to be an independent risk factor for RVO.
    • The study did not establish a link between homocysteine levels and severe RVO prognosis.
    • The efficacy of vitamin therapy for RVO prevention or treatment requires further investigation.